Interpath is a pioneering Australian joint health company specialising in the research and development of advanced, scientifically proven 4CYTE products. 4CYTE’s signature range, developed for people and animals, represents a breakthrough in the treatment of joint injury and degenerative diseases such as arthritis and osteoporosis. Bringing together patented, premium quality natural ingredients with the latest in molecular and cellular biology techniques, 4CYTE products work towards repairing and restoring damaged joints, and actively maintaining joint health. The regenerative power of the exclusive active ingredient, Epiitalis, is a game-changer within the joint health industry, which, in the past, often limited its focus to pain relief and symptom management. As leaders in joint health, our dedication to evolving the science of this field is ongoing. Interpath are deeply proud of the trust our customers place in us to guide them on the path of leading happier, healthier and more active lives.
Stand Number: 202